logo

For the Inventor, By the Inventor

Glostrup, Denmark

Morten Langgård

USPTO Granted Patents = 47 

 

Average Co-Inventor Count = 5.6

ph-index = 7

Forward Citations = 140(Granted Patents)


Location History:

  • Valby, DK (2018 - 2020)
  • Glostrup, DK (2012 - 2023)

Company Filing History:

goldMedal46 out of 506 
 
H. Lundbeck A/s
 patents
silverMedal1 out of 832,843 
Other
 patents

Years Active: 2012-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
PDE1 Inhibitors
PDE9 Inhibitors
PDE10A Enzyme Inhibitors
Imidazopyrazinones
Pyrazolo[4,3-B]pyridines
Quinoline Derivatives
Tricyclic Imidazole Compounds
Halogenated Quinazolin-THF-Amines
Macrocycles
Heteroaromatic Phenylimidazole Derivatives
Combination Treatments
N-Substituted Phthalamic Acids
47 patents (USPTO):Explore Patents
1. 11851425 - Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines (2023-12-26),
2. 11634416 - Combination treatments comprising administration of 1H-pyrazolo[4,3-b]pyridines (2023-04-25),
3. 11535611 - Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors (2022-12-27),
4. 11491140 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2022-11-08),
5. 11472810 - Imidazopyrazinones as PDE1 inhibitors (2022-10-18),
6. 11104680 - 1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitors (2021-08-31),
7. 11026924 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2021-06-08),
8. 11026923 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2021-06-08),
9. 10912773 - Combinations comprising substituted imidazo[1,5-a]pyrazinones as PDE1 inhibitors (2021-02-09),
10. 10905688 - Combinations comprising substituted imidazo[1,5-α]pyrazinones as PDE1 inhibitors (2021-02-02),
11. 10858362 - Imidazopyrazinones as PDE1 inhibitors (2020-12-08),
12. 10806718 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2020-10-20),
13. 10766893 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2020-09-08),
14. 10689379 - Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors (2020-06-23),
15. 10633382 - Imidazopyrazinones, pyrazolopyrimidinones and pyrazolopyridinones as PDE1 inhibitors (2020-04-28),

Title: The Innovative Journey of Morten Langgård

Introduction: Morten Langgård, a talented inventor hailing from Glostrup, Denmark, has made significant contributions to the field of innovation with his creative mind and dedication to problem-solving.

Latest Patents: Morten Langgård's latest patents showcase his expertise in developing cutting-edge technologies in the medical device industry, focusing on improving patient outcomes and healthcare efficiency.

Career Highlights: Throughout his career, Morten Langgård has demonstrated a keen ability to translate ideas into tangible inventions that have the potential to impact lives positively. His innovative spirit and commitment to excellence have earned him recognition as a leading figure in the innovation landscape.

Collaborations: Morten Langgård has collaborated with various research institutions, universities, and companies to bring his inventions to life. His partnerships have been instrumental in advancing his ideas from concept to reality, showcasing his ability to work effectively in multidisciplinary teams.

Conclusion: Morten Langgård's journey as an inventor exemplifies the power of innovation in driving positive change. His relentless pursuit of excellence and passion for creating solutions to complex challenges continue to inspire the next generation of inventors and innovators worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…